A decline in breast-cancer incidence [18]

New England Journal of Medicine

Volumn 357, Issue 5, 2007, Pages 512-513

  Signorello, Lisa B ^a   Tarone, Robert E ^a  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

BREAST CANCER; CANCER INCIDENCE; CAUCASIAN; HEALTH CENTER; HORMONE SUBSTITUTION; HUMAN; LETTER; MENOPAUSE; NEGRO; PATIENT COMPLIANCE; PRIORITY JOURNAL; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; UNITED STATES;

EID: 34547626226     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-45.
2. Signorello LB, Hargreaves MK, Steinwandel MD, et al. Southern Community Cohort Study: establishing a cohort to investigate health disparities. J Natl Med Assoc 2005;97:972-9.
3. Wei F, Miglioretti DL, Connelly MT, et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. In: Vogt TM, Wagner EH, eds. Health care systems as research platforms: the cancer research network. Journal of the National Cancer Institute monographs. No. 35. Bethesda, MD: Oxford University Press, 2005:106-12.
4. Hillman JJ, Zuckerman IH, Lee E. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program. J Womens Health (Larchmt) 2004;13:986-92.